NasdaqGM:CRMDPharmaceuticals
CorMedix (CRMD) Is Down 11.1% After CEO Becomes Chair And Sets 2026 Revenue Target - Has The Bull Case Changed?
Earlier this month, CorMedix Inc. reshaped its leadership structure by naming CEO Joseph Todisco as Chairman of the Board, appointing Mike Seckler as EVP & Chief Commercial Officer, and issuing new 2026 revenue guidance of US$300 million to US$320 million.
This combination of leadership consolidation, fresh commercial expertise, and quantified revenue expectations gives investors clearer insight into how CorMedix plans to run and grow the business.
We’ll now examine how Todisco’s expanded...